DK1202954T3 - Nye aminobenzophenoner - Google Patents

Nye aminobenzophenoner

Info

Publication number
DK1202954T3
DK1202954T3 DK00943698T DK00943698T DK1202954T3 DK 1202954 T3 DK1202954 T3 DK 1202954T3 DK 00943698 T DK00943698 T DK 00943698T DK 00943698 T DK00943698 T DK 00943698T DK 1202954 T3 DK1202954 T3 DK 1202954T3
Authority
DK
Denmark
Prior art keywords
alkyl
similar
different substituents
represents hydrogen
formula
Prior art date
Application number
DK00943698T
Other languages
Danish (da)
English (en)
Inventor
Erik Rytter Ottosen
Fredrik Bjoerkling
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Application granted granted Critical
Publication of DK1202954T3 publication Critical patent/DK1202954T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ophthalmology & Optometry (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK00943698T 1999-07-16 2000-07-11 Nye aminobenzophenoner DK1202954T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14406599P 1999-07-16 1999-07-16
PCT/DK2000/000384 WO2001005744A1 (fr) 1999-07-16 2000-07-11 Nouvelles aminobenzophenones

Publications (1)

Publication Number Publication Date
DK1202954T3 true DK1202954T3 (da) 2004-02-09

Family

ID=22506899

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00943698T DK1202954T3 (da) 1999-07-16 2000-07-11 Nye aminobenzophenoner

Country Status (18)

Country Link
US (1) US6624199B1 (fr)
EP (1) EP1202954B1 (fr)
JP (1) JP2003505359A (fr)
KR (1) KR20020013961A (fr)
CN (1) CN1231459C (fr)
AT (1) ATE251117T1 (fr)
AU (1) AU768473B2 (fr)
CA (1) CA2379316A1 (fr)
DE (1) DE60005689T2 (fr)
DK (1) DK1202954T3 (fr)
ES (1) ES2204639T3 (fr)
HK (1) HK1048304B (fr)
HU (1) HUP0201910A3 (fr)
NZ (1) NZ516824A (fr)
PL (1) PL353645A1 (fr)
PT (1) PT1202954E (fr)
RU (1) RU2243964C2 (fr)
WO (1) WO2001005744A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20021940A3 (cs) * 1999-12-06 2003-01-15 Leo Pharma A/S Aminobenzofenony jako inhibitory IL-1beta a TNF-alfa
CA2408727A1 (fr) 2000-05-22 2001-11-29 Leo Pharma A/S Benzophenones comme inhibiteurs de l'il-1.beta. et tnf-.alpha.
GB0107368D0 (en) * 2001-03-23 2001-05-16 Novartis Ag Organic compounds
WO2003015789A2 (fr) * 2001-08-15 2003-02-27 Leo Pharma A/S Composition pharmaceutique pour application cutanee
MXPA04001912A (es) 2001-08-28 2004-07-23 Leo Pharma As Aminobenzofenonas novedosas.
US20030225089A1 (en) * 2002-04-10 2003-12-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
EP1707205A2 (fr) 2002-07-09 2006-10-04 Boehringer Ingelheim Pharma GmbH & Co. KG Compositions pharmaceutiques contenant un antichlinergique et un inhibiteur du p38 pour le traitement de maladies respiratoires
JP4939216B2 (ja) 2003-07-24 2012-05-23 レオ ファーマ アクティーゼルスカブ 新規アミノベンゾフェノン化合物
WO2005110422A2 (fr) 2004-05-19 2005-11-24 Boehringer Ingelheim International Gmbh Procede pour traiter des maladies et des etats associes a un niveau modifie de peptides beta amyloides et nouveaux composes d'enolcarboxamide
US20060035893A1 (en) 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
KR101260236B1 (ko) 2004-12-13 2013-05-06 레오 파마 에이/에스 트리아졸 치환된 아미노벤조페논 화합물
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
FR2894821B1 (fr) * 2005-12-15 2008-02-29 Galderma Res & Dev Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
EP1992344A1 (fr) 2007-05-18 2008-11-19 Institut Curie P38 alpha comme cible therapeutique pour les maladies associées á une mutation de FGFR3
EP2206534A1 (fr) 2008-10-09 2010-07-14 c-a-i-r biosciences GmbH Dérivés de dibenzocycloheptanone et produits pharmaceutiques comprenant ces composés

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9701453D0 (en) * 1997-01-24 1997-03-12 Leo Pharm Prod Ltd Aminobenzophenones

Also Published As

Publication number Publication date
WO2001005744A1 (fr) 2001-01-25
DE60005689T2 (de) 2004-08-05
HUP0201910A2 (hu) 2002-12-28
CA2379316A1 (fr) 2001-01-25
AU5806700A (en) 2001-02-05
CN1368950A (zh) 2002-09-11
US6624199B1 (en) 2003-09-23
HUP0201910A3 (en) 2006-03-28
NZ516824A (en) 2004-03-26
AU768473B2 (en) 2003-12-11
ES2204639T3 (es) 2004-05-01
CN1231459C (zh) 2005-12-14
HK1048304B (zh) 2006-04-21
DE60005689D1 (de) 2003-11-06
EP1202954A1 (fr) 2002-05-08
KR20020013961A (ko) 2002-02-21
ATE251117T1 (de) 2003-10-15
HK1048304A1 (en) 2003-03-28
PT1202954E (pt) 2004-02-27
PL353645A1 (en) 2003-12-01
EP1202954B1 (fr) 2003-10-01
JP2003505359A (ja) 2003-02-12
RU2243964C2 (ru) 2005-01-10

Similar Documents

Publication Publication Date Title
DK1202954T3 (da) Nye aminobenzophenoner
DK0931788T3 (da) Metalloproteasehæmmere
HK1053463A1 (en) Aminobenzophenones as inhibitors of il-1B and TNF-a.
HK1048465A1 (en) Aminobenzophenones as inhibitors of il-1B and tnf-a.
HUP0300268A2 (hu) Herbicid hatású benzoilpirazolszármazékok, ilyeneket tartalmazó készítmények és alkalmazásuk
EP1535910A4 (fr) Derives de quinoleine et derives de quinazoline inhibiteurs de l'autophosphorylation du recepteur du facteur stimulant la proliferation des macrophages
GB0226593D0 (en) Compounds
TW364903B (en) Halogenopyrimidines
ATE302775T1 (de) Carbolinderivate
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
ATE346067T1 (de) Carbolinderivate
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
HRP20050082A2 (en) 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
EP1357124A4 (fr) Composes heterocycliques et compositions ameliorant les fonctions cerebrales contenant ces derniers comme principe actif
SE9903290D0 (sv) Novel compounds
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
MXPA04009421A (es) Compuestos de tiazol-2-ilimina como inhibidores de la pde-7.
MXPA05006957A (es) Nuevos derivados de fosforamida.
ES2180201T3 (es) Derivados de azetidinona para el tratamiento de infecciones por hcmv.
BR9902096A (pt) Pitazóis.
ES2166710A1 (es) Nuevos compuestos heterociclicos con actividad antiinflamatoria.
GB0427491D0 (en) Process and compounds
SE0401308L (sv) Anordning för lampanslutning
AP2001002047A0 (en) Isoquinoliness as urokinase inhibitors.